Studies related to Treatment of Parkinson's and Creatine

Effect Of Creatine Monohydrate On Clinical Progression In Patients With Parkinson Disease: A Randomized Clinical Trial

Effect None
Trial Design Randomized trial
Trial Length 6+ Months
Number of Subjects 1741
Sex Female
Age Range 45-64, 65+
Body Types Obese, Overweight, Average
Notes for this study:
Participants with early-stage Parkinson’s disease (within 5 years of diagnosis) who also underwent dopaminergic therapy were randomized to receive a placebo or 5 g of creatine twice a day (10 g/day) for a minimum of 5 years. At a preplanned checkpoint, however, the trial was terminated early for futility, as no difference in clinical function (using 5 different scales) was observed between the placebo and creatine groups.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.